About: Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Dafna D. Gladman et al published 29 January 2019 in Arthritis Research and Therapy

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 2019 (uk) im Januar 2019 veröffentlichter wissenschaftlicher Artikel (de) article by Dafna D. Gladman et al published 29 January 2019 in Arthritis Research and Therapy (en)
publication date	wds:Q61806742-6589536F-3270-4BB2-8ADC-ADBC2B1671E4
publication date	2019-01-29 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q61806742-D73DF0B0-7E19-433D-9258-17800E4907F0
language of work or name	English
exact match	wds:Q61806742-F08C3AC4-80C6-48AF-B6C9-18080428D0F2
exact match	https://scigraph.springernature.com/pub.10.1186/s13075-019-1831-0
cites work	wds:Q61806742-004E2C5E-E6CC-4769-9417-552F5996A980 wds:Q61806742-0485E6B2-3286-4574-8907-28F846A80ED5 wds:Q61806742-0BBA04CE-5BA8-4FE4-9AB2-67E35CDFA780 wds:Q61806742-0BF99423-95A2-4ABC-A838-E7E4C423DFA0 wds:Q61806742-16623E87-CCFD-4F89-B84A-61A6BDA6ED32 wds:Q61806742-222E9ADF-1BFE-465B-8651-017839B4078A wds:Q61806742-2F6C1787-778B-4810-940D-009616DB32C4 wds:Q61806742-33441273-C5CA-44BF-808A-312F06F5C089 wds:Q61806742-3C5B49B4-21BF-4A36-8668-19C70F5526B0 wds:Q61806742-45793641-E8A6-47D8-BD9C-DEC50FC51E96 wds:Q61806742-598A779A-CC6D-49C3-8DE7-051B164F86F1 wds:Q61806742-5EC7DA82-A98F-43A9-BF7E-65FD3F662DE6 wds:Q61806742-6A7DCD03-501E-4A12-B7FA-F86112D236C8 wds:Q61806742-6DF73474-73A9-49DE-A5D7-60953560ADF0 wds:Q61806742-729A3904-CE32-4246-9084-AFED468DBA0D wds:Q61806742-783C5B0F-2384-4DE5-85CF-33FAD7CC7E5D wds:Q61806742-790C02E4-BE7D-47C4-8878-97374C3E3119 wds:Q61806742-90B2B34A-CB4E-4B47-9A45-0987CE5381F9 wds:Q61806742-9A50E261-81C2-40A0-9308-C208B4642BA8 wds:Q61806742-9C8A73FF-C00A-431A-A0D2-EFC439E8B43D wds:Q61806742-A8416322-29B2-4EF9-8931-55800737B822 wds:Q61806742-AE0C6168-2442-46EC-9C05-10FB4856E490 wds:Q61806742-B45EE692-7ED3-4E1E-89B5-3A69E0199646 wds:Q61806742-BE5D5C9C-EACD-460E-AD47-CDAD5A3EEA5D wds:Q61806742-D046AD1C-41FE-47E8-AED3-CEAE29B7D9D4 wds:Q61806742-D89E07A0-6214-4B6E-BEEC-1B13823123F6 wds:Q61806742-DECFC00B-11D7-4FBF-958B-F6A91E0AD4D2 wds:Q61806742-DFA0617D-BDA9-4E6C-B202-82723106DC79 wds:Q61806742-E66F89E8-23CD-42D2-AB9E-99AC8F990546 wds:Q61806742-F0D52BCF-3E46-4B94-AFDB-034860F9DF24
cites work	Psoriatic arthritis: a unified concept twenty years on. Development of a disease activity index for the assessment of reactive arthritis (DAREA) Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis Defining enthesitis in spondyloarthritis by ultrasound: results of a Delphi process and of a reliability reading exercise Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Sca Measurement of patient outcome in arthritis Minimally important difference of Health Assessment Questionnaire in psoriatic arthritis: relating thresholds of improvement in functional ability to patient-rated importance and satisfaction. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Asse Psoriatic arthritis: epidemiology, clinical features, course, and outcome The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales Development of an assessment tool for dactylitis in patients with psoriatic arthritis Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study Measuring dactylitis in clinical trials: which is the best instrument to use? Enthesitis in psoriatic disease Dactylitis in psoriatic arthritis: a marker for disease severity? Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled perio Psoriatic arthritis: Epidemiology, diagnosis, and treatment The Epidemiology of Psoriatic Arthritis Enthesitis: A hallmark of psoriatic arthritis. Psoriatic Arthritis Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial Clinical Enthesitis in a Prospective Longitudinal Psoriatic Arthritis Cohort: Incidence, Prevalence, Characteristics, and Outcome. Systematic review of treatment effectiveness and outcome measures for enthesitis in psoriatic arthritis Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. GRAPPA 2011: proceedings from the ultrasound imaging module Psoriatic arthritis indices The problem in differentiation between psoriatic-related polyenthesitis and fibromyalgia. Development of a Preliminary Ultrasonographic Enthesitis Score in Psoriatic Arthritis - GRAPPA Ultrasound Working Group
author name string	wds:Q61806742-09D58020-12D4-4CEB-8636-FAAC0B8D1CC3 wds:Q61806742-543CA427-CACC-42DA-9DC0-8992586685EE wds:Q61806742-56EA4D34-A155-4E9A-9273-BF82C534EEF5 wds:Q61806742-6A12D514-F9CC-4FAB-A094-FE6045E4D334 wds:Q61806742-724E0797-07F7-44C6-A68C-85A1CA22DF24 wds:Q61806742-C6CF43DC-9EBA-4B07-8D5F-3A30709A6055 wds:Q61806742-D4B96BBA-AB7A-4E7D-9929-9D608F4D04DF wds:Q61806742-DFB82122-24C9-4ED7-8186-758CF0F39746
author name string	Ana-Maria Orbai Helena Marzo-Ortega Julie Birt James Cheng-Chung Wei Gaia Gallo Suchitrita Rathmann David Shrom Uta Klitz
rdfs:label	Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis (en) Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis (nl)
skos:prefLabel	Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis (en) Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis (nl)
name	Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis (en) Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis (nl)
author	wds:Q61806742-59ED8683-916D-4226-BE4A-BA49B9120AEF
author	Dafna D. Gladman
title	wds:Q61806742-FCD99435-04F7-42DF-9BEA-ED44ACE5FA22
title	Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis (en)
page(s)	wds:Q61806742-7E4E2BB7-F680-4C6A-90D3-E1A762E4198A
page(s)	38
instance of	wds:Q61806742-E63CD055-9BC8-410E-A4C1-86F24154A14B

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software